Evidence map›Paper›PMID 18627035›Full record

ArticleJournal of neuroscience research2008

Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid a antibody in campylobacteriosis.

Seigo Usuki, Yoshihiko Nakatani, Kyoji Taguchi, Tetsuhiro Fujita, Shinya Tanabe, Iku Ustunomiya, Yihua Gu, Shaun A Cawthraw, Diane G Newell, Mohanasundari Pajaniappan and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Seigo UsukiInstitute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia 30912-2697, USA.
Yoshihiko Nakatani
Kyoji Taguchi
Tetsuhiro Fujita
Shinya Tanabe
Iku Ustunomiya
Yihua Gu
Shaun A Cawthraw
Diane G Newell
Mohanasundari Pajaniappan
Stuart A Thompson
Toshio Ariga
Robert K Yu
Augusta University · USShowa Pharmaceutical University · JP

Funding

ROLE OF GLYCOLIPIDS IN EXPERIMENTAL NEUROPATHYR01NS026994 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI YU, ROBERT K. · 1988 to 2012
$3.3M
Campylobacter jejuni outer membrane protein vaccineR01AI058284 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI THOMPSON, STUART A · 2004 to 2009
$1.9M
Campylobacter jejuni proteins induced at 37CR01AI055715 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI THOMPSON, STUART A · 2003 to 2007
$1.4M
Campylobacter jejuni DNA methylation and gene regulationR21AI061026 · NIAID · MEDICAL COLLEGE OF GEORGIA (MCG) · PI THOMPSON, STUART A · 2004 to 2004
$320k
NIAID NIH HHS R01 AI055715NIAID NIH HHS R01 AI058284NIAID NIH HHS R21 AI061026NINDS NIH HHS R01 NS026994NINDS NIH HHS R01 NS26994
6 · The paper itself

Abstract

An infecting strain VLA2/18 of Campylobacter jejuni was obtained from an individual with campylobacteriosis and used to prepare chicken sera by experimental infection to investigate the role of serum anti-ganglioside antibodies in Guillain-Barré syndrome. Both sera of the patient and chicken contained anti-ganglioside antibodies and anti-Lipid A (anti-Kdo2-Lipid A) antibodies directed against the lipid A portion of the bacterial lipooligosaccharide. The anti-Kdo2-Lipid A activities inhibited voltage-gated Na (Nav) channel of NSC-34 cells in culture. We hypothesized that anti-Kdo2-Lipid A antibody acts on the functional inhibition of Nav1.4. To test this possibility, a rabbit peptide antibody (anti-Nav1.4 pAb) against a 19-mer peptide (KELKDNHILNHVGLTDGPR) on the alpha subunit of Nav1.4 was produced. Anti-Nav1.4 pAb was cross-reactive to Kdo2-Lipid A. Anti-Kdo2-lipid A antibody activity in the chicken serum was tested for the Na(+) current inhibition in NSC-34 cells in combination with mu-Conotoxin and tetrodotoxin. Contrary to our expectations, the anti-Kdo2-Lipid A antibody activity was extended to Nav channels other than Nav1.4. By overlapping structural analysis, it was found that there might be multiple peptide epitopes containing certain dipeptides showing a structural similarity with v-Lipid A. Thus, our study suggests the possibility that there are multiple epitopic peptides on the extracellular domains of Nav1.1 to 1.9, and some of them may represent target sites for anti-Kdo2-Lipid A antibody, to induce neurophysiological changes in GBS by disrupting the normal function of the Nav channels.

Indexed as

Amino Acid SequenceAnimalsAntibody SpecificityAutoantibodiesAutoantigensBlotting, WesternCampylobacter InfectionsCampylobacter jejuniChickensCross ReactionsEnzyme-Linked Immunosorbent AssayEpitopes, B-LymphocyteGangliosidesHumansImmunohistochemistryLipid AAutoantibodiesAutoantigensEpitopes, B-LymphocyteGangliosidesLipid APeptidesProtein IsoformsSodium Channels

Identifiers

PMID18627035
PMCPMC2631156
OpenAlexW2062086057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.